Beximco Pharmaceuticals Limited's latest marketcap:
As of 07/05/2025, Beximco Pharmaceuticals Limited's market capitalization has reached $315 M. According to our data, Beximco Pharmaceuticals Limited is the 17345th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 315 M |
| Revenue (ttm) | 376.11 M |
| Net Income (ttm) | 51.57 M |
| Shares Out | 446.11 M |
| EPS (ttm) | 0.12 |
| Forward PE | 6.85 |
| Ex-Dividend Date | 11/26/2024 |
| Earnings Date | 11/03/2025 |
Beximco Pharmaceuticals Limited's yearly market capitalization.
| Date | Market Cap(BDT) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 315 M | 6.62% | 17345 |
| 12/30/2024 | 36.4 B | -44.19% | 16391 |
| 12/28/2023 | 65.22 B | 0% | 11896 |
| 12/29/2022 | 65.22 B | -24.13% | 10820 |
| 12/30/2021 | 85.97 B | 1.15% | 9294 |
| 12/30/2020 | 84.98 B | 201.95% | 7971 |
| 12/30/2019 | 28.15 B | -12.26% | 12233 |
| 12/27/2018 | 32.08 B | -23.8% | 10463 |
| 12/28/2017 | 42.1 B | 28.47% | 10353 |
| 12/29/2016 | 32.77 B | 0.88% | 10094 |
Company Profile
About Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals Limited is a leading manufacturer and marketer of generic pharmaceutical formulations and active pharmaceutical ingredients (APIs) in Bangladesh. Established in 1976 and headquartered in Dhaka, the company serves both domestic and international markets.
Product Portfolio
The company offers a diverse range of pharmaceutical products, including:
- Allergic disorder treatments
- Analgesics and antipyretics
- Anti-infectives and antivirals
- Cardiovascular and CNS medications
- Cough, cold, and respiratory products
- Endocrine and diabetes care
- Eye care and gastrointestinal solutions
- Hormones, steroids, and IV fluids
- Oncology and musculoskeletal treatments
- Urogenital and skincare products
- Vitamin and mineral supplements
Dosage Forms
Beximco Pharmaceuticals produces medications in various forms:
- Solid and liquid formulations
- Creams, ointments, and suppositories
- Metered dose and dry powder inhalers
- Nasal sprays and sterile injectables
- Lyophilized injectables and large volume IV fluids
Additional Services
The company provides contract manufacturing services to other pharmaceutical firms, leveraging its expertise in generic drug production.
With operations spanning since 1976, Beximco Pharmaceuticals continues to expand its presence through both domestic operations and exports to international markets.
Frequently Asked Questions
-
What is Beximco Pharmaceuticals Limited's (DSE-BXPHARMA) current market cap?As of 07/05/2025, Beximco Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $315 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Beximco Pharmaceuticals Limited (DSE-BXPHARMA) rank globally by market cap?Beximco Pharmaceuticals Limited global market capitalization ranking is approximately 17345 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.